Skip to Main Content

Paper Details

Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer.
Cancer Res
4
2023
AXL, HNC, HNC tumors, HRAS, HRAS mutations, HRAS oncogene, HRASmut, HRASmut cells, HRASmut human HNC cell lines, HRASmut tumors, Head and Neck Cancer, Hippo, Mutant HRAS, Tipifarnib, VEGFA, VEGFC, YAP1, farnesyltransferase, head and neck cancer, human, lung, mutant HRAS, mutated HRAS, patient, patients, syngeneic model, tipifarnib, tumor
Author NameAffiliation
Dinorah Friedmann-MorvinskiTel Aviv University
Dinorah Friedmann-MorvinskiTel Aviv University
Alan L HoMemorial Sloan Kettering Cancer Center
Alan L HoWeill Cornell Medical College
Jennifer R GrandisUniversity of California San Francisco
Jennifer R GrandisUniversity of California San Francisco
Jorge Silvio GutkindUniversity of California San Diego
  • 1 - 7

Datasets

Release 1.2